Finally, a multivariate analysis should have been carried out to jointly evaluate the prognostic impact of HMGB1 concentrations, PD-L1 expression, and other outcome-related factors such as tumor size and TNM stage. The gene discussed is HMGB1; the disease is neoplasm.